Crossmark

The effective duration of systemic therapy and the neutrophil-to-lymphocyte ratio predict the surgical advantage of primary tumor resection in patients with de novo stage IV breast cancer: a retrospective study

Crossref DOI link: https://doi.org/10.1186/s12957-024-03586-0

Published Online: 2024-11-14

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sugihara, Rie

Watanabe, Hidetaka

Matsushima, Shuntaro

Katagiri, Yuriko

Saku, Shuko

Okabe, Mina

Takao, Yuko

Iwakuma, Nobutaka

Ogo, Etsuyo

Fujita, Fumihiko

Toh, Uhi
License Information

Text and Data Mining valid from 2024-11-14

Version of Record valid from 2024-11-14
More Information

Article History

Received: 19 September 2024

Accepted: 5 November 2024

First Online: 14 November 2024

Declarations

:

: The study protocol was approved by the Ethics Committee of Kurume University (no. 22278). All work described in this study has been carried out in accordance with the Declaration of Helsinki.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below